Related by context. All words. (Click for frequent words.) 73 HEPLISAV Phase 73 candidate REP# 73 investigational hepatitis B 72 HEPLISAV TM 70 Anturol ® 70 Acetavance TM intravenous acetaminophen 69 DPX Survivac 69 polysaccharide polymer 69 candidate deforolimus 68 Crofelemer budesonide foam 68 HEPLISAV TM hepatitis B 68 candidate TNFerade biologic 68 Hematide TM 68 SynCon 68 TransVax ™ 68 Xcytrin R 68 Hematide ™ 68 commercialize CorMedix drug 68 Surfaxin LS 67 GVAX R 67 TransVax tm 67 orBec R oral beclomethasone 67 vosaroxin 67 PANVAC VF 67 GVAX ® 67 Oral NKTR 67 pharmacogenomic translational research 67 torezolid phosphate 67 KRYSTEXXA TM pegloticase 67 RH1 targeted chemotherapeutic agent 67 XP# XP# 67 Chimigen TM 67 Aganocide 66 Empatic ™ 66 Neo Kidney Augment 66 IMPDH inhibitor 66 SinuNase TM novel 66 ALTROPANE R 66 Synavive ™ 66 SynCon TM DNA 66 subsidiaries visit http:/www.apricusbio.com 66 anti botulism antibody 66 Panzem R 66 XL# anticancer compounds 66 Archexin 66 molecular imaging radiopharmaceutical 66 Nicotine Conjugate Vaccine 66 orBec ® oral beclomethasone 66 apricitabine ATC 66 successfully commercialize Iluvien 66 JZP 66 CMV vaccine 66 Initiates Phase II 66 HepeX B TM 66 oncolytic virus therapies 65 oral prodrug 65 please visit http:/www.sunesis.com 65 Hematide ™ peginesatide 65 R#/MEM # 65 BiovaxID TM 65 OvaRex R 65 tivozanib AV 65 oral picoplatin 65 TRIOLEX HE# APOPTONE HE# 65 StaphVAX R 65 Naglazyme R 65 Kosan dependence 65 SinuNase ™ 65 HuMax TAC 65 Completes Patient Enrollment 65 Submits Biologics License Application 65 Phase 2a clinical trials 65 Spiegelmer ® 65 non nucleoside HCV 65 sapropterin dihydrochloride Phase 65 TNFerade ™ 64 motexafin gadolinium Injection 64 include Phenoptin TM 64 AN# novel 64 Zemiva ™ 64 LibiGel ® testosterone gel 64 treats acute lymphoblastic 64 Submits NDA 64 lead molecular radiotherapeutic 64 XL# XL# XL# XL# 64 Files Investigational 64 please visit www.advaxis.com 64 recombinant PSMA vaccine 64 Initiates Clinical 64 HDL Mimetic Peptide 64 confirmatory pivotal 64 BEMA Granisetron 64 Auxilium transmucosal film 64 Androxal TM 64 HepeX B 64 visit www.targanta.com 64 candidate ATHX 64 Zemiva TM 64 Entereg TM 64 Successfully Completes Phase 64 PrevOnco 64 TransVax TM 64 includes TOLAMBA TM 64 sodium glucose transporter 64 BHT DNA 64 Evoltra ® 64 HuCAL antibodies 64 staphylococcal vaccine 64 novel therapeutic antibodies 64 Veronate R 64 novel L DOS# 64 ONCONASE R 64 tramiprosate Alzhemed TM 64 Zemplar Capsules 64 Amigal TM 64 commercialize deforolimus ARIAD 64 SPL# Gel vaginal microbicide 64 include GALNS N 64 sapacitabine CYC# 64 Vaccine Adjuvant 64 IMA# 64 personalized dendritic 64 rxRNA 64 Nanobody R 64 Staphylococcus aureus Polysaccharide Conjugate 64 RNAi therapeutic platform 64 XOMA 3AB 64 R MSCRAMM 63 Prodarsan R 63 Canvaxin TM 63 SinuNase TM 63 APC Targeting Technology 63 technology visit http:/www.genmab.com 63 Vaxfectin TM formulated 63 Biologic License Application BLA 63 EVIZON TM squalamine lactate 63 Submits Response 63 ionotropic glutamate receptor antagonists 63 Perflubutane Polymer Microspheres 63 oral talactoferrin 63 LEVADEX ™ 63 granted Ortec 63 thrombin component 63 Exelixis compounds 63 TBC M4 63 visit www.genenews.com 63 Entereg alvimopan 63 Personalized Immunotherapy 63 Q#IR 63 faropenem medoxomil 63 oral taxane 63 AFREZZA ® 63 TELINTRA R 63 virus HCV protease inhibitor 63 evaluating bafetinib 63 RELOVAIR ™ 63 XL# XL# 63 TOCOSOL Camptothecin 63 PREOS R 63 initiate multicenter 63 DermaVir Patch 63 including eniluracil ADH 63 Initiate Clinical Trial 63 TRO# 63 Bayer HealthCare Onyx Pharmaceuticals 63 molecular chaperone regulation 63 topical anti infective 63 overactive bladder AA# 63 Vaxfectin 63 Shigamabs ® 63 targeted radiotherapeutic 63 highly purified pasteurized 63 MAA submission 63 M# rationally 63 H#N# VLP vaccine 63 AAG geldanamycin analog 63 Duromist ™ 63 Acetavance TM 63 PROVENGE ® 63 immuno therapeutic 63 next generation URAT1 63 intranasal insulin product 63 MKC# MT 63 HuMax CD#b 62 developing ostarine selective 62 AdVac ® 62 RiVax 62 SynCon ™ DNA 62 PDX pralatrexate 62 vaginally administered lidocaine 62 dimebon latrepirdine 62 Begins Dosing 62 Pentad TM 62 Neo Kidney Augment ™ 62 Testosterone MDTS ® 62 RIGScan CR 62 Zenvia ™ 62 Ostarine ™ 62 candidate Gencaro TM 62 Maxy G# 62 Cinryze ™ 62 intravenous acetaminophen 62 Prednisporin TM 62 website www.celsion.com 62 ZFP Therapeutics 62 Initiates Enrollment 62 Nektar proprietary 62 recombinant subunit vaccine 62 generation URAT1 inhibitor 62 Trofex 62 please visit www.middlebrookpharma.com 62 Phase 1a clinical 62 PORxin TM 62 inhaled AAT 62 Immunotherapeutic 62 Zemiva TM Trofex TM 62 Trofex ™ 62 Veronate 62 Intermezzo ® zolpidem tartrate 62 Initiates Clinical Trial 62 trastuzumab DM1 T DM1 62 cosmetic cosmeceutical products 62 Anturol TM 62 forodesine hydrochloride 62 candidate XP# 62 Antibody Discovery 62 Japanese Encephalitis Vaccine 62 Panzem ® 62 Androxal ® 62 Nabi HB Intravenous 62 Solazed TM 62 Protexia ® 62 dutogliptin 62 Presents Preclinical 62 JVRS 62 Reports Preclinical Data 62 alvespimycin 62 seasonal influenza VLP vaccine 62 acetonide FA 62 CB2 selective receptor agonist 62 LibiGel ® 62 BRILINTA 62 Prednisporin 62 Glufosfamide 62 Dyloject TM 62 topical antifungal product 62 Thalomid R 62 MOZOBIL 62 JAK2 Inhibitor 62 compound INCB# 62 VLP influenza 62 Vaxfectin R formulated 62 commercialize ZYFLO CR 62 Aeolus Pharmaceuticals Announces 62 Fibrillex TM 62 Nasulin ™ 62 TransVax 62 candidate CRLX# 62 muscarinic receptor agonist 62 IIa clinical 62 candidate Puricase 62 clinical trials Archexin 62 include PLX IBD 62 PLK1 SNALP 62 Micromet proprietary BiTE 62 Allovectin 7 r 62 PrevOnco ™ 62 Alnylam #x# 62 Vaxfectin ® 62 Diamyd R 62 DIFICID ™ 61 visit www.sciclone.com 61 Telik logo TELINTRA 61 pharmacokinetic PK study 61 PDE4 inhibitor 61 Intercell vaccine 61 Exherin TM 61 dextofisopam 61 clinical trials dacetuzumab SGN 61 SILENOR 61 TBC# 61 Tovaxin TM 61 Pruvel 61 THR beta agonist 61 TRACON Pharmaceuticals 61 cathepsin K inhibitor 61 potentially treat nephropathic 61 selectin antagonist 61 R vitespen 61 CD# CEA 61 aldehyde dehydrogenase ALDH2 deficiency 61 mitogen activated ERK kinase 61 mertansine 61 ELND-#/AZD-# 61 therapeutic monoclonal antibody 61 mesylate tablets approved 61 preclinical efficacy 61 VitiGam TM 61 ChimeriVax JE 61 FACTIVE R gemifloxacin 61 seliciclib CYC# 61 intranasal formulation 61 Presents Preclinical Data 61 HCV RNA polymerase 61 CRMD# 61 Inc. www.micromet inc.com 61 DOS# 61 neuropathic pain metabolic diseases 61 R roscovitine 61 rPA anthrax vaccine 61 TRANSDUR Bupivacaine 61 product TNFerade TM 61 IV APAP 61 SuperAntibody 61 Novavax VLP 61 ARISE Phase III 61 Unit Dose Budesonide 61 LEVADEX TM 61 LibiGel NDA 61 sodium Injection 61 number NCT# ClinicalTrials.gov 61 Bellicum 61 signal detection CTSD 61 Multiple Ascending Dose 61 Files IND 61 MSCRAMM R 61 SURFAXIN 61 agonistic human 61 novel oral anticoagulant 61 Genasense ® oblimersen 61 Asentar TM 61 Troxatyl 61 sNDAs 61 REG2 Regado 61 Syncria albiglutide 61 IRX 2 61 FluINsure 61 vii Cubist ability 61 OTC ZEGERID 61 proprietary intravenous formulation 61 lintuzumab SGN 61 developing ACAPODENE 61 proprietary Isolagen Process 61 Matrix Phase 2b 61 LymphoStat B TM 61 BLA filing 61 zileuton CR 61 maximally tolerated dose 61 Celator 61 NPC 1C 61 oral isotype selective HDAC 61 HGS ETR2 61 topically applied SEPA 61 SynCon TM 61 sterile lidocaine patch 61 MSCRAMM ® 61 personalized cellular immunotherapy 61 MCSP respectively 61 lucinactant 61 Polymer Microspheres 61 anti CD3 monoclonal 61 ThermoDox ® clinical 61 BiTE R 61 cGMP manufacture 61 Solazed 61 inflammatory autoimmune diseases 61 Rigel R# 61 markets Testim ® 61 BrachySil TM 61 Ceragenin ™ 61 MKC# 61 Genasense R oblimersen 61 Zoraxel TM 61 Affilin ® 61 P#X# antagonist 61 PNP inhibitor 61 balsalazide tablet 61 liposomal formulation 61 Allovectin 7 R 61 Harbor BioSciences 61 sumatriptan DosePro 61 Alfacell proprietary ribonuclease 61 HQK 61 programs visit http:/www.bionovo.com 60 AzaSite Plus 60 oral immunomodulatory 60 Lisofylline LSF 60 Poly ICLC 60 humanized therapeutic 60 Protexia R 60 2 methoxyestradiol 60 Thelin TM 60 transmucosal delivery system 60 Bioaccelerate compounds under 60 VEGFR2 inhibitor 60 DCVax R 60 ruxolitinib 60 Genz # 60 Aurexis 60 Tarmogen 60 candidates Azedra TM 60 Phase lll 60 Initiated Phase 60 see www.virexx.com 60 personalized dendritic cell 60 MOVIPREP R 60 AMITIZA ® 60 Announces Tentative Approval 60 Pandemic Influenza Vaccine 60 hypoxia activated prodrug 60 targets Galectin receptors 60 CCX# 60 VIAject R 60 please visit http:/www.atherogenics.com 60 CEQ# 60 delivers fluocinolone acetonide FA 60 non nucleoside inhibitor 60 HCD# [002] 60 MAGE A3 ASCI 60 drug GLPG# 60 Budesonide foam crofelemer 60 Fodosine 60 Surfaxin lucinactant 60 Iluvien ® 60 Trastuzumab DM1 60 pan histone deacetylase 60 molecular therapeutics immunotherapies 60 drug ISA# 60 Vaxfectin TM 60 novel peptides 60 Anavex #-# 60 proprietary capillary aerosolization 60 REG2 60 Cardio Vascu Grow 60 Fx #A 60 ALN PCS 60 PDE# inhibitors 60 Harry Palmin President 60 pDNA vaccine 60 HepaGam B 60 novel emulsion formulation 60 Phase 2b Clinical Trial 60 REMINYL ® 60 DepoVax ™ vaccine 60 Aganocide ® 60 Omigard 60 investigational pharmacologically unique 60 oral beclomethasone dipropionate 60 www.accentia.net 60 candidate Liposomal Grb 60 5 lipoxygenase inhibitor 60 HuLuc# 60 HCV protease inhibitors 60 SILENOR ™ 60 GLP toxicology studies 60 MoxDuo ® IR 60 FOLOTYN ® 60 TRIOLEX HE# 60 IMPACS R 60 Arno Therapeutics 60 Submits Investigational 60 transmucosal delivery 60 Adnectin 60 novel histone deacetylase 60 refractory chronic lymphocytic 60 TRIOLEX ™ 60 NU# direct 60 Anticalin R 60 REGN# 60 autologous cellular immunotherapy 60 Exherin 60 COLAZAL R 60 Insulin Nasal Spray 60 AFFITOME R 60 intravenous iclaprim potent 60 Chemophase 60 Elagolix 60 pafuramidine 60 Dyax phage display 60 REGiMMUNE 60 ART# 60 synDNA 60 please visit www.sucampo.com 60 leading oral taxane 60 Phase 1b Clinical Trial 60 PD2i ® algorithm 60 PI3K/Akt pathway inhibitor 60 highly selective adenosine 60 volociximab 60 AIMM trial 60 bucindolol hydrochloride 60 receptor inhibiting monoclonal 60 Allovectin 7 60 Panzem R NCD 60 platform HDL Mimetic 60 defensin mimetic antibiotic 60 trivalent seasonal flu 60 TKM Ebola 60 generation PNP inhibitor 60 Locteron ® 60 TKM PLK1 60 Azedra TM 60 Azedra ™ 60 Behcet uveitis 60 PORxin TM platforms 60 JAK inhibitor 60 Novavax VLP vaccine 60 tubulin inhibitor 60 NOX E# 60 PHX# 60 influenza VLP vaccine 60 dacetuzumab SGN 60 HIV coinfected 60 Generx ™ 60 tezampanel NGX# 60 Anidulafungin 60 Receives Fast Track 60 Presents Positive 60 TPI ASM8 60 telaprevir VX 60 Ketotransdel 60 Achieves Primary Endpoint 60 Phase III Pivotal 59 TLR9 agonist 59 Angiocept 59 Pivotal Phase 59 non porcine pancreatic 59 dose intramuscular 59 Vaxfectin R adjuvant 59 GlycoPEGylated hemostasis compounds 59 G#DT 59 HuCNS SC ® 59 selective immunoproteasome inhibitor 59 human IgG1 monoclonal 59 targeted antifolate 59 romidepsin novel 59 AdVac 59 TKB# 59 www.pranabio.com 59 UPLYSO 59 ENMD # 59 KNS # 59 GVAX cancer 59 Factor VIIa 59 Micromet BiTE 59 MEND CABG II 59 diabetes irritable bowel 59 Cintredekin Besudotox 59 INTEGRILIN R eptifibatide Injection 59 Azedra 59 Captisol ® 59 Phase III ADT 59 include Healive 59 developing TB4 59 2 inhibitor CYT# 59 Phase 2b Trial 59 Hedgehog antagonist 59 LymphoStat B belimumab 59 recombinant biopharmaceutical 59 MKC# MKC# PP 59 Synerx 59 SAR# [002] 59 purified inactivated vaccine 59 telomerase therapeutic 59 Alequel TM 59 treatment naive genotype 59 product candidate Lpathomab 59 MyVax ® 59 synthetic anti infective 59 HDL Selective Delipidation 59 Cerashield ™ 59 ARRY # 59 flu mAb 59 candidate ridaforolimus 59 PRT# 59 SYCREST 59 Intercell Japanese Encephalitis 59 NRGN 59 www.aastrom.com 59 CCR5 mAb 59 AdhTAP 59 metaglidasen 59 sores onychomycosis nail 59 SUTENT ® 59 JAK#/JAK# inhibitor CYT# 59 Zolpimist ™ 59 CYT# vascular disrupting 59 BENLYSTA ® 59 Genasense oblimersen sodium Injection 59 CYT# potent vascular disrupting 59 Civacir 59 CIP TRAMADOL ER 59 include Altastaph TM 59 Antibody Drug Conjugate 59 Simulect 59 initiated Phase Ib 59 Therapeutic Vaccine 59 Ostabolin C TM 59 kidney urologic 59 Maribavir 59 Urocidin TM 59 elotuzumab 59 Luramist TM 59 alemtuzumab MS 59 fidaxomicin Phase 59 HCV polymerase 59 Callisto initiated 59 Entereg R 59 fusion enhancers 59 Sopherion 59 website http:/www.celsion.com 59 OMAPRO ™ 59 Eniluracil 59 concerning CombinatoRx 59 novel VDA molecule 59 DepoVax TM 59 Trofex TM 59 zolpidem tartrate sublingual tablet 59 CINQUIL 59 OvaRex ® MAb 59 Mpex 59 prematurity Stargardt disease 59 DP VPA 59 immunotherapeutic approaches 59 Biopharmaceuticals AG 59 HCV polymerase inhibitor 59 Potelligent Technology 59 CCR9 antagonist 59 dextromethorphan quinidine 59 Rotarix ® 59 hoFH 59 GALNS 59 JOULFERON 59 Bilive TM 59 Doxycycline Tablets 59 targeting Inflammatory Bowel 59 gastro intestinal inflammation 59 Prodarsan ® 59 addressing idiopathic pulmonary 59 3 registrational trial 59 Activity Assay 59 Plicera 59 Dacogen injection 59 Etubics 59 midstage clinical 59 please visit http:/www.vandapharma.com 59 Telatinib 59 TOCOSOL Paclitaxel 59 Provenge sipuleucel T 59 PAION AG ISIN 59 ARIKACE ™ 59 SNT MC# 59 Quinamed 59 ROTARIX 59 EndoTAG TM 59 pradefovir 59 please visit www.tranzyme.com 59 solid tumors ZYBRESTAT 59 AFREZZA TM 59 Soliris TM eculizumab 59 drug pipeline TAFA# 59 Aflunov 59 budesonide MMX Phase III 59 adecatumumab MT# 59 SARcode 59 Juvaris BioTherapeutics 59 FluCide 59 RhuDex ® 59 bardoxolone 59 unique PER.C6 59 immatics 59 tramiprosate ALZHEMED TM 59 Genitope Corporation 59 IV acetaminophen 59 NEUMUNE 59 MAXY VII 59 CIP ISOTRETINOIN 59 Stephen Ghiglieri 59 Solorel 59 www.cellgenesys.com 59 deforolimus 59 SYGNIS 59 IND submission 59 PEGylated interferon 59 Hybridon 59 include Alferon N 59 initiated Phase 1b 59 Diamyd r 59 Vaxfectin R 59 ZK EPO 59 adrenergic regulation 59 Initiate Phase 59 QNEXA ® 59 Diamyd ® 59 LE SN# 59 palifosfamide Zymafos TM 59 Alzhemed TM 59 MorphoSys proprietary 59 Troxatyl TM 59 EGS# 59 developing Zerenex ferric 59 Zingo TM 59 IL# PE#QQR 59 Meets Primary Endpoint 59 albiglutide 59 candidate Lovaxin C 59 Pruvel TM 59 SURFAXIN r 59 Universal Flu Vaccine 59 BiTE antibody 59 Topline Results 59 symbol AVXL 59 www.medicago.com 59 Icatibant 58 Amoxicillin PULSYS 58 therapeutic monoclonal antibodies 58 confirmatory clinical 58 RhuDex 58 Aerosurf 58 Phase III multicenter 58 Difimicin 58 SIX RO ROG 58 cobiprostone 58 Valtropin 58 Linjeta TM 58 SNS# T 58 VISICOL R 58 faropenem 58 ASONEP 58 oral gallium 58 investigational humanized monoclonal antibody 58 interferon gamma 1b 58 orally inhaled migraine 58 Systemic Delivery 58 unique alkylating agent 58 NTDDS 58 L BLP# 58 Chemokine Therapeutics 58 Aganocide R 58 ALN VSP Phase 58 HuMax 58 telomerase inhibitor drug 58 isoform selective 58 OncoVEX 58 NeuroSTAT ® 58 proprietary BiTE ® 58 Annamycin 58 phase IIa clinical 58 valent pneumococcal conjugate vaccine 58 please visit www.palmharbor.com 58 Phase Ib study 58 Phase #b/#a clinical 58 Phase 1b clinical trials 58 Qnexa TM 58 Hsp# Inhibitor 58 DNA methyltransferase inhibitors 58 rhMBL 58 BioMAP ® Systems 58 rhLF 58 hyaluronidase enzyme 58 Alzheimer disease cognitive dysfunction 58 TOCOSOL 58 pralatrexate injection folate analogue 58 HIV integrase inhibitors 58 CELVAPAN H#N# 58 oral salmon calcitonin 58 ZFP Therapeutic 58 inhaled liposomal ciprofloxacin 58 OraTest R 58 Predictive medicine 58 Vertex hepatitis C 58 pharmacodynamic PD 58 Qutenza TM 58 StemEx R 58 Onconase 58 Announces Poster Presentations 58 Oracea TM 58 investigational immunotherapy 58 Fast Track Status 58 hepatitis B measles mumps 58 histamine dihydrochloride 58 BioVant 58 ACAPODENE TM 58 topical gel formulation 58 trivalent influenza vaccine 58 GRNVAC1 58 sodium thiosulfate STS 58 Triapine R 58 omacetaxine mepesuccinate 58 selective androgen receptor modulator 58 Aurora Kinase 58 Risperidone Oral Solution 58 Guanilib 58 Bioral Amphotericin B 58 maturation inhibition 58 Phase III Clinical Trial 58 Optiquel ™ 58 Triolex 58 www.allos.com 58 oral dihydropyrimidine dehydrogenase DPD 58 Syntonix 58 Commences Phase 58 ASX PGL 58 KemPharm 58 MAXY G# 58 please visit www.metabolon.com 58 refractory gout 58 MAXY alpha 58 Panzem NCD 58 IMC #B 58 Forodesine 58 VersaFilm 58 using Crucell PER.C6 58 Protease Inhibitor 58 DexaSite 58 MoxDuo IR 58 Aflibercept 58 www.novartis.com 58 GATTEX ™ 58 baminercept 58 forodesine 58 ARIKACE TM 58 ATL/TV# 58 evaluating satraplatin 58 Phase IIb trials 58 selective orally bioavailable 58 Onalta 58 EHT AGN 58 evaluating mipomersen 58 #D#C# 58 SPRIX ® 58 EcoNail TM 58 PREFLUCEL 58 Twinrix 58 SparVax ™ 58 urocortin 2 58 Sulonex TM 58 Omthera 58 Myocet 58 Anthim 58 Tezampanel 58 visit www.genmab.com 58 CTAP# Capsules 58 systemic Phase 1b 58 INSPIRE Trial Phase III 58 Idera Pharmaceuticals 58 LEP ETU 58 CYT# NicQb 58 delivery polymer matrix 58 Nasdaq IDRA today 58 Zavesca r 58 biomarkers predictive 58 APTIMA HPV assay 58 Varespladib 58 Medidur TM FA 58 KRN# 58 AusAm 58 Numoda 58 Vitaxin 58 mTOR kinase 58 MEK Inhibitor 58 serine protease inhibitor CU# 58 Nasdaq NPSP 58 Proellex TM 58 tolevamer 58 Merck Suspends Lobbying 58 Therapeutic Competitors Companies 58 Cloretazine ® 58 LE DT 58 Aryplase 58 ASONEP TM 58 http:/www.marinabio.com 58 recombinant hepatitis B 58 TM Aganocide 58 Solzira ™ 58 immunotherapeutic vaccine 58 lorvotuzumab mertansine 58 Receives Tentative FDA 58 Proxinium TM 58 Camvia 58 Dual Opioid TM 58 TRANSDUR ® 58 LAB CGRP 58 ALN TTR 58 AMPAKINE CX# 58 t2cure GmbH 58 mGluR5 NAM 58 TÎ ² 4 58 Inhalation Solution 58 OpenArray ® 58 Ophthotech 58 proprietary PEGylation 58 orally dosed 58 Hyphanox 58 AERx iDMS 58 Phase Ib II 58 DEB# 58 Zalypsis 58 THALOMID 58 Kamada AAT 58 Selective Electrochemical Tumor Ablation 58 midstage trials 58 Medidur ™ FA 58 Augment TM 58 ® bortezomib 58 Nasdaq ACHN 58 Initiates Clinical Trials 58 selective estrogen receptor modulator 58 Pancreate 58 LUCASSIN 58 Vaxfectin TM adjuvant 58 budesonide foam 58 Visit www.BASInc.com 58 KL4 Surfactant 57 miRNA therapeutics 57 HGS ETR1 mapatumumab 57 Alferon LDO 57 IMiDs ® 57 Shigamabs R 57 Tesmilifene 57 androgen receptor modulator 57 SCIB1 57 VALOR trial 57 Initiates Phase 57 Nventa proprietary CoVal 57 Second Pivotal Phase 57 ACIP recommended 57 TLK# 57 immunosuppressive compound 57 cancer indications bafetinib 57 Phase IIb clinical trials 57 eTag assays 57 Cardioxyl 57 Inotek Pharmaceuticals Corporation 57 ILUVIEN ® 57 Multimeric 57 triple VEGF receptor 57 otelixizumab 57 Peyronie disease Frozen Shoulder 57 vivo toxicology 57 Phase IIa Clinical Trial 57 MAP# 57 Intravenous CP 57 compound ISA# 57 http:/www.anadyspharma.com 57 Talabostat 57 Restanza TM 57 VLP vaccine 57 PEG PAL 57 cellular immunotherapy 57 Xanafide 57 Muraglitazar 57 chemotherapy induced neutropenia 57 Nipent R 57 CRD5 57 Pimavanserin 57 oral nucleoside analogue 57 ABL inhibitor 57 TELINTRA 57 Stimuvax R 57 Captisol enabled 57 indiplon capsules 57 oral methylnaltrexone 57 subcutaneous PRO 57 NS5b 57 Phase IIb Clinical Trial 57 Panzem 57 selective S#P# receptor agonist 57 Testosterone MDTS R 57 brentuximab vedotin SGN 57 PS# DARA 57 Vaccinex 57 INCB# [001] 57 im peramivir 57 Hepatitis C Virus HCV 57 Accelerated Intelligent 57 endothelin antagonist 57 nonclinical studies 57 synDNA TM 57 MT#/MEDI-# 57 Virosome Biologicals 57 Cloretazine R VNP#M 57 HuCAL PLATINUM 57 AeroLEF TM 57 oral proteasome inhibitor 57 rALLy trial 57 NuroPro R 57 Psoraxine R 57 LEAPS TM 57 CB2 selective 57 RenaZorb TM 57 CDP# 57 Pandemic Flu Vaccine 57 Loramyc TM 57 Altastaph 57 TOLAMBA 57 anti idiotype 57 % uracil topical 57 Romidepsin